Helps cancer patients take oral medicines as prescribed
Part of Cancer clinical trials.
This study tests a set of practical support steps to help people with advanced cancer take their oral (by mouth) treatment medicines correctly. It may help improve adherence and reduce missed doses or appointments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have advanced cancer being treated with an oral (by mouth) medication
- Your cancer diagnosis matches one of these: stage III/IV colorectal, stage IV breast, stage IV lung (non-small cell), stage IV kidney, stage IV ovarian, multiple myeloma, CML on a TKI, myelodysplastic syndrome on lenalidomide, GIST (as an adjuvant treatment), CLL, metastatic prostate, hepatocellular carcinoma, stage IV melanoma, or myelofibrosis/myeloproliferative neoplasm
- You are well enough to participate (performance status below 3)
- You do not currently receive chemotherapy and radiation at the same time
- You can give informed consent in English and have not had repeated missed clinic visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help cancer patients who are starting their first oral chemo pill at home. It aims to improve understanding and safety of taking these medications.
This trial tests a program to help teenagers and young adults take their oral cancer medications as prescribed. It aims to make medication routines easier and improve adherence.
This study tests whether a smartphone app (Caaring®) can help monitor cancer patients who take oral medications. If you are on an oral cancer treatment and comfortable using a smartphone, this trial may help you stay connected with your care team and manage side effects from home.
This trial tests whether combining regular medication safety checks with electronic tracking of side effects can improve quality of life and help reduce economic burden for people taking cancer pills. It’s for people starting oral cancer therapy and using connected technology to report symptoms.
This trial studies whether a “DROP” support program helps ambulatory people with cancer manage drug-related problems when they start or change oral (by mouth) anticancer treatment. It may help reduce medication mistakes and complications by improving how you handle your regimen at home.
This study follows patients who take oral anticancer drugs and take part in a special monitoring program at Lyon-Sud hospital. It aims to understand what affects treatment safety and outcomes.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.